Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Interest Income Expense
Burning Rock Biotech Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Interest Income Expense
¥17.5m
|
CAGR 3-Years
89%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Interest Income Expense
-¥1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Interest Income Expense
-¥67.8m
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Interest Income Expense
¥217.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
134%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Interest Income Expense
-¥41.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
-84%
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Interest Income Expense
¥100.8m
|
CAGR 3-Years
126%
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Interest Income Expense?
Interest Income Expense
17.5m
CNY
Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's Interest Income Expense amounts to 17.5m CNY.
What is Burning Rock Biotech Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
89%
Over the last year, the Interest Income Expense growth was 59%. The average annual Interest Income Expense growth rates for Burning Rock Biotech Ltd have been 89% over the past three years .